These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 23324379)
21. Mutual regulation of follicle-stimulating hormone signaling and bone morphogenetic protein system in human granulosa cells. Miyoshi T; Otsuka F; Suzuki J; Takeda M; Inagaki K; Kano Y; Otani H; Mimura Y; Ogura T; Makino H Biol Reprod; 2006 Jun; 74(6):1073-82. PubMed ID: 16436528 [TBL] [Abstract][Full Text] [Related]
22. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development. Okamoto M; Murai J; Yoshikawa H; Tsumaki N J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523 [TBL] [Abstract][Full Text] [Related]
23. Community effect triggers terminal differentiation of myogenic cells derived from muscle satellite cells by quenching Smad signaling. Yanagisawa M; Mukai A; Shiomi K; Song SY; Hashimoto N Exp Cell Res; 2011 Jan; 317(2):221-33. PubMed ID: 20965167 [TBL] [Abstract][Full Text] [Related]
24. The role of bone morphogenetic proteins in endochondral bone formation. Tsumaki N; Yoshikawa H Cytokine Growth Factor Rev; 2005 Jun; 16(3):279-85. PubMed ID: 15869898 [TBL] [Abstract][Full Text] [Related]
25. A unique mutation of ALK2, G356D, found in a patient with fibrodysplasia ossificans progressiva is a moderately activated BMP type I receptor. Fukuda T; Kanomata K; Nojima J; Kokabu S; Akita M; Ikebuchi K; Jimi E; Komori T; Maruki Y; Matsuoka M; Miyazono K; Nakayama K; Nanba A; Tomoda H; Okazaki Y; Ohtake A; Oda H; Owan I; Yoda T; Haga N; Furuya H; Katagiri T Biochem Biophys Res Commun; 2008 Dec; 377(3):905-9. PubMed ID: 18952055 [TBL] [Abstract][Full Text] [Related]
26. [Cytokines in bone diseases. BMP signaling and fibrodysplasia ossificans progressiva]. Katagiri T; Kamizono J; Nakashima Y; Kitoh H; Susami T; Haga N Clin Calcium; 2010 Oct; 20(10):1510-7. PubMed ID: 20890033 [TBL] [Abstract][Full Text] [Related]
27. Endofin acts as a Smad anchor for receptor activation in BMP signaling. Shi W; Chang C; Nie S; Xie S; Wan M; Cao X J Cell Sci; 2007 Apr; 120(Pt 7):1216-24. PubMed ID: 17356069 [TBL] [Abstract][Full Text] [Related]
29. Characterization of bone morphogenetic protein 4 receptor in fibrodysplasia ossificans progressiva. Lanchoney TF; Olmsted EA; Shore EM; Gannon FA; Rosen V; Zasloff MA; Kaplan FS Clin Orthop Relat Res; 1998 Jan; (346):38-45. PubMed ID: 9577408 [TBL] [Abstract][Full Text] [Related]
30. Ter94/VCP is a novel component involved in BMP signaling. Zeng Z; de Gorter DJ; Kowalski M; ten Dijke P; Shimmi O PLoS One; 2014; 9(12):e114475. PubMed ID: 25469707 [TBL] [Abstract][Full Text] [Related]
31. The BMP signaling and in vivo bone formation. Cao X; Chen D Gene; 2005 Aug; 357(1):1-8. PubMed ID: 16125875 [TBL] [Abstract][Full Text] [Related]
32. Measurement of constitutive activity of BMP type I receptors. de Gorter DJ; van Dinther M; Ten Dijke P Methods Enzymol; 2010; 484():281-93. PubMed ID: 21036238 [TBL] [Abstract][Full Text] [Related]
33. Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling. Hartung A; Bitton-Worms K; Rechtman MM; Wenzel V; Boergermann JH; Hassel S; Henis YI; Knaus P Mol Cell Biol; 2006 Oct; 26(20):7791-805. PubMed ID: 16923969 [TBL] [Abstract][Full Text] [Related]
34. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway. Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456 [TBL] [Abstract][Full Text] [Related]
35. Increased PLEKHO1 within osteoblasts suppresses Smad-dependent BMP signaling to inhibit bone formation during aging. Liu J; Liang C; Guo B; Wu X; Li D; Zhang Z; Zheng K; Dang L; He X; Lu C; Peng S; Pan X; Zhang BT; Lu A; Zhang G Aging Cell; 2017 Apr; 16(2):360-376. PubMed ID: 28083909 [TBL] [Abstract][Full Text] [Related]
36. Discovery of Heterotopic Bone-Inducing Activity in Hard Tissues and the TGF-β Superfamily. Katagiri T; Tsukamoto S; Nakachi Y; Kuratani M Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30428615 [TBL] [Abstract][Full Text] [Related]
37. BMP-SMAD-ID promotes reprogramming to pluripotency by inhibiting p16/INK4A-dependent senescence. Hayashi Y; Hsiao EC; Sami S; Lancero M; Schlieve CR; Nguyen T; Yano K; Nagahashi A; Ikeya M; Matsumoto Y; Nishimura K; Fukuda A; Hisatake K; Tomoda K; Asaka I; Toguchida J; Conklin BR; Yamanaka S Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13057-13062. PubMed ID: 27794120 [TBL] [Abstract][Full Text] [Related]
38. Competition between type I activin and BMP receptors for binding to ACVR2A regulates signaling to distinct Smad pathways. Szilágyi SS; Amsalem-Zafran AR; Shapira KE; Ehrlich M; Henis YI BMC Biol; 2022 Feb; 20(1):50. PubMed ID: 35177083 [TBL] [Abstract][Full Text] [Related]
39. Negative regulation of BMP signaling by the ski oncoprotein. Luo K J Bone Joint Surg Am; 2003; 85-A Suppl 3():39-43. PubMed ID: 12925608 [TBL] [Abstract][Full Text] [Related]
40. Unique players in the BMP pathway: small C-terminal domain phosphatases dephosphorylate Smad1 to attenuate BMP signaling. Knockaert M; Sapkota G; Alarcón C; Massagué J; Brivanlou AH Proc Natl Acad Sci U S A; 2006 Aug; 103(32):11940-5. PubMed ID: 16882717 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]